The company is currently applying its novel solution to enable customers to meet the specific serialisation demands of China and South Korea
Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation, which provides pharma customers with flexible, efficient and reliable technological resource that enables full and fast compliance with all the varying serialisation regulations across the globe, is currently applying its novel solution to enable customers to meet the specific serialisation demands of China and South Korea
The modular technology and system has the distinct benefit of being the same for all countries, whilst enabling pharma customers to meet specific serialisation regulations that vary markedly across different nation states and regions. The highly flexible solution has the capability to maintain data in multiple formats bespoke to each country’s individual regulatory rules. Consequently, customers are provided with a resource that ensures all serialisation requirements can be managed locally.
The implementation of serialisation services for the Chinese market, one of the world’s most complex for serialisation regulations, took under six months for Aesica to complete. The company’s serialisation module is also already on hand for customers that need to satisfy the demands of Brazil, the especially complex serialisation regulations of Turkey and Argentina and those faced by EU countries.
EP News Bureau – Mumbai
Comments are closed.